(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.34%) $0.935
(0.56%) $11.01
(0.17%) $0.801
(0.00%) $92.17
5 days till quarter result
(bmo 2024-05-03)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative skin sensitizing potency assessment of chemicals; and GARDair, an in vitro test for identifying chemical respiratory sensitizers, as well as GARDskin medical device, an in vitro skin sensitization testing for medical devices and solid materials...
Stats | |
---|---|
今日成交量 | 10 070.00 |
平均成交量 | 21 434.00 |
市值 | 153.53M |
EPS | SEK0 ( 2020-08-19 ) |
下一个收益日期 | ( SEK0 ) 2024-05-03 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -7.01 |
ATR14 | SEK0.101 (1.58%) |
SenzaGen AB 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
SenzaGen AB 财务报表
Annual | 2023 |
营收: | SEK49.87M |
毛利润: | SEK34.93M (70.05 %) |
EPS: | SEK-0.910 |
FY | 2023 |
营收: | SEK49.87M |
毛利润: | SEK34.93M (70.05 %) |
EPS: | SEK-0.910 |
FY | 2022 |
营收: | SEK41.77M |
毛利润: | SEK27.34M (65.44 %) |
EPS: | SEK-1.030 |
FY | 2021 |
营收: | SEK15.42M |
毛利润: | SEK9.45M (61.30 %) |
EPS: | SEK-1.350 |
Financial Reports:
No articles found.
SenzaGen AB
SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative skin sensitizing potency assessment of chemicals; and GARDair, an in vitro test for identifying chemical respiratory sensitizers, as well as GARDskin medical device, an in vitro skin sensitization testing for medical devices and solid materials. It also provides irritation and corrosion testing services. The company offers services through license partners and distributors. It has a collaboration agreement with the Research Institute for Fragrance Materials to develop tests for photosensitization. The company was incorporated in 2010 and is headquartered in Lund, Sweden.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。